Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Medplus Health IPO is 47. Their analysis recommends May Subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 47 | May Subscribe |
[Dilip Davda] After a dismal performance for FY20, the company posted super earnings and based on these earnings, it has priced its IPO very aggressively. While the sustainability of such margins going forward raises concern, pricing of the IPO too appears greedy. Cash surplus investors may consider an investment with a long-term perspective, others may ignore. Read detail review...
Medplus Health IPO Reviews, analysis and views by popular members. Read Medplus Health Services Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP